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Absence of antibodies to Rickettsia spp.,
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Background: In the Pacific islands countries and territories, very little is known about the incidence of infectious
diseases due to zoonotic pathogens. To our knowledge, human infections due to Rickettsia spp., Coxiella burnetii,
Ehrlichia spp. and Bartonella spp. have never been reported in French Polynesia; and infections due to C. burnetti
have been reported worldwide except in New Zealand. To evaluate the prevalence of this disease, we conducted a
serosurvey among French Polynesian blood donors.
Methods: The presence of immunoglobulin G antibodies against R. felis, R. typhi, R. conorii, C. burnetii, B. henselae,
B. quintana, and E. chaffeensis was evaluated by indirect immunofluorescence assay in sera from 472 French
Polynesian blood donors collected from 2011 to 2013. In addition, 178 ticks and 36 cat fleas collected in French
Polynesia were also collected and tested by polymerase chain reaction to detect Rickettsia spp., B. henselae and
Ehrlichia spp.
Results: None of the blood donors had antibodies at a significant level against Rickettsia spp., Coxiella burnetii,
Ehrlichia spp. and Bartonella spp. All tested ticks and cat fleas were PCR-negative for Rickettsia spp., B. henselae, and
Ehrlichia spp.
Conclusion: We cannot conclude that these pathogens are absent in French Polynesia but, if present, their
prevalence is probably very low. C. burnetii has been reported worldwide except in New Zealand. It may also be
absent from French Polynesia.
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Background
French Polynesia (FP) is an Oceanian overseas territory of
the French republic located in the south Pacific (274,000
inhabitants; 118 islands of which 67 are inhabited). It is
one of the 22 Pacific Island Countries and Territories
(PICTs) of the Oceania region. All PICTs conduct public
health surveillance activities and submit their data to re-
gional and international agencies. Laboratory facilities in
PICTs include 20 level one laboratories (for screening
tests) and 4 level two laboratories (for confirmation tests)
[1]. When needed, specimens for specialized assays are re-
ferred to reference, or level 3, laboratories located in USA,
Australia, New Zealand and France. Most often, frozen
shipment of samples to level 3 laboratories is impossible.
As few laboratory facilities are available in this region,
little is known about the incidence and geographical
distribution of infectious diseases due to neglected
pathogens [2]. With the exception of leptospirosis
known to be endemic in FP [3], there are few data
available about the presence and incidence of bacterial
zoonoses in this territory. In an effort to evaluate the
seroprevalence against Rickettsia spp., agents of rickett-
sioses [4,5], C. burnetii, the agent of Q fever [6], Barto-
nella spp., agents of a variety of human and animal
diseases [7] and Ehrlichia spp., agents of human erhli-
chioses [8], we conducted a serosurvey among 472 blood
donors from Tahiti in collaboration with the French* Correspondence: dmusso@ilm.pf1Pôle de recherche et de veille sur les maladies infectieuses émergentes,
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Polynesian blood bank centre (Papeete, FP) and the French
Reference centre for Rickettsiosis (Marseille, France).
Methods
A total of 472 blood donor samples collected from July
2011 to July 2013 were included in this study. None of
them were collected specifically for the purpose of this
study. Written consent was obtained by the blood bank
centre from all blood donors before blood sampling.
The study was approved by the Ethics Committee of
the “Institut Fédératif de Recherche” 48, Aix-Marseille
University, Marseille, France, under reference 13–021.
A medical questionnaire was completed for all blood
donors in accordance to the recommendations for
blood donation policies, including the number of years
of residency in FP. Serological tests were performed on
samples collected for biological qualification of blood
units. All samples were anonymized by the blood bank
centre before testing for Rickettsia spp., Bartonella
spp., Ehrlichia spp. and Coxiella burnetii. Four groups
of blood donors were differentiated: natives from FP
who never travelled abroad (group 1), natives from FP
who travelled abroad for less than 1 week (group 2), na-
tives from FP who travelled abroad for more than
1week (group 3), and immigrants (group 4). All study
participants were healthy voluntary blood donors older
than 18years old, and were all previously tested nega-
tive by the laboratory of the blood bank centre for HIV,
HBV, HCV, HTLV, and Treponema pallidum.
The presence of immunoglobulin G class antibodies
(IgG) against Rickettsia. felis, R. typhi, R. conorii, C. burnetii
(total IgG), Bartonella henselae, B. quintana, and Ehrlichia
chaffeensis was determined by indirect immunofluores-
cence assay (IFA) (the reference method for the serodiag-
nosis of infections caused by these bacteria), as previously
described [9-13]. All sera were screened at a dilution of
1:50 and those positive at 1:50 were diluted and tested by
IFA to determine end titers. One negative and one positive
control (for each bacterium) were used for each set of 8
blood donors’ samples.
In addition, 178 ticks collected form dogs and cows
and 36 fleas collected from dogs in 2012 in Tahiti, the
main FP island, were identified according to standard
taxonomic identification keys, and tested individually by
polymerase chain reaction (PCR) to detect Rickettsia
spp., B. henselae and Ehrlichia spp. as previously re-
ported [14].
Results
Numbers of blood donors in each group, age (mean,
standard deviation and median) and number of years of
residence in FP (mean, standard deviation and median)
are reported in Table 1. All tested blood donors lived in
Tahiti.
IFA screening at the 1:50 dilution detected 23 positive
sera, 9 for both R. typhi and R. conorii, 11 for C. burnetii,
and 3 for both B. quintana and B. henselae. All positive
sera were negative at the dilution of 1:100. According to
the recommended IFA cutoff values for these diseases [6],
all 472 blood donors were considered as non reactive
against the tested antigens.
It should be noted that none of the 11 patients with
sera positive at 1:50 for C. burnetii were from group 1
and 5 of them were from French immigrants living in
French Polynesia. Only 2 of the 9 positive sera at 1:50
for both R. typhi and R. conorii were from group 1 and
none of those positive at 1:50 for both B. quintana and
B. henselae were from group 1.
Ticks were identified as Rhipicephalus sanguineus (132)
or Boophilus annulatus (46), and fleas as Ctenocephalides
felis. All ticks and cat fleas were tested negative by PCR
for Rickettsia spp., B. henselae and Ehrlichia spp.
Discussion
In PICTs, rickettsioses, Q fever, bartonelloses and ehrli-
chioses are not included in the list of nationally notifi-
able diseases. Therefore, their local epidemiology may
Table 1 Repartition of blood donors
Natives from FP Immigrants Total
Group 1 Group 2 Group 3 Total natives Group 4
Number of blood donors 102 215 23 340 132 472
Age
Mean 32.1 34.9 34.5 34 42.6 36.5
Standard deviation 11.4 11.8 10.5 11.7 12.8 12.6
Median 31 32 31 32 42 35
Years of residence in FP
Mean 32.1 34.9 30 33.7 15.7 28.8
Standard deviation 11.4 11.8 10.8 11.7 13 14.5
Median 31 32 29 32 12.5 28
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only be extrapolated from investigations of outbreaks, ser-
osurveys or public health and reference laboratory data.
Regarding rickettsioses, very few data are available
from the whole Oceania region [15]. R. felis, the agent of
flea-borne rickettsiosis, has been identified in Western
Australia [16], New Zealand [17] and in New Caledonia
[18]. Tick-borne rickettsioses have been reported in
Australia: Queensland tick typhus (R. australis), Flinders
Island spotted fever (R. honei) and variant Flinders Is-
land spotted fever (R. honei strain “marmionii”) [19].
Bartonella henselae has been detected from New Cale-
donia children suffering from hepatic abscesses [20] and
from cat fleas in New Zealand [17]. Bartonella clarrid-
geiae, suggested to be a minor etiologic agent of cat-
scratch disease in humans has been isolated from cat fleas
in FP [21], New Zealand [17] and New Caledonia [18].
Few serosurveys have been conducted in the Pacific
region. In Queensland (Australia), a 5.6% seroprevalence
of antibodies to at least one Rickettsia group (spotted
fever, typhus and scrub typhus groups) was found among
920 human sera tested in 1996 [22]. In the same area, a
6.5% seroprevalence of antibodies to C. burnetii was de-
tected among 447 sera collected in 2001 and 2002 [23].
Serosurveys conducted among blood donors were also
informative: in southern France, a 18% seroprevalence
of antibodies to R. conorii and 5% to C. burnetii was
identified among 325 blood donors [24]; in 500 Tunisian
blood donors, seroprevalences of antibodies to R. conorii,
R. typhi and C. burnetti were found to be 9%, 3.6% and
26%, respectively [25]; in Spain, a 23.1% seroprevalence
of antibodies to C. burnetii was found among 863 blood
donors [26]; in 601 Turkish blood donors, a 32.3% sero-
prevalence of antibodies to C. burnetii was detected [27];
in Mauritania, 13.5, 19.6, 1.7 and 33% seroprevalences of
antibodies to R. conorii, R. africae, R. typhi and C. bur-
netti, respectively, were observed among 118 blood do-
nors and patients [28]; and in New Zealand, 5% of 140
blood donors had antibodies to B. henselae [29].
The blood donors included in this serosurvey study
are representative of the French Polynesian population
because 340 (72%) of them are natives from French
Polynesia. Natives from French Polynesian are 87% ac-
cording to the French Polynesian Institute of Statistics.
They are also informative for past exposure to the stud-
ied bacteria because the mean duration of residency in
FP was 33.7 years for native and 15.7 years for immi-
grant blood donors. Finally, based on the serosurveys
detailed above, all of which detecting seroprevalences to
Rickettsia spp., Bartonella and/or C. burnetii of 1.7 to
32.3% among populations of 118 to 601 blood donors, we
believe that the 472 blood donor population that we tested
is not too small to conclude that the seroprevalence of
antibodies to the various tested pathogens is very low in
French Polynesia.
The absence of antibodies to the investigated agents in
FP may be explained by several factors. First, the arthro-
pod vectors of rickettsiae and ehrlichiae may be absent
in FP. To date, two tick species have been described in
this territory, including Rhipicephalus sanguineus and
Boophilus annulatus [30,31], the former being a known
vector of spotted fever rickettsioses in other parts of the
world. Our results confirmed that all 178 collected ticks
were either R. sanguineus or B. annulatus ticks, but all
were PCR-negative for Rickettsia spp., B. henselae and
Ehrlichia spp. Therefore, currently, there is no proof that
ticks may harbor human pathogens in FP. In addition,
although C. felis fleas are proven vectors of R. felis and
B. henselae in many areas worldwide [5], all 36 tested
cat fleas in our study were PCR-negative. Thus, as B.
henselae was not detected in cat fleas and cat-scratch
disease is not diagnosed in children in FP, we assume
that cats in this territory are not infected. Few numbers
of ruminants (goats, sheep, cattle), the reservoirs of C.
burnetii, are present in FP. In addition, FP has very strict
importation criteria for animals and plants. For pets and
ruminants notably, a quarantine period and a non conta-
giosity certificate are mandatory before introduction of
the animal. In 1996, a Q fever serosurvey conducted on
306 farms mammals (sheep and goats) by the veterinary
department of the French Polynesian Ministry of Health
detected no positive. Therefore, we believe that Q fever
is absent from FP. Furthermore, as the disease is also
absent from New Zealand [32], we assume that it may
be absent from most of the Pacific Ocean area.
Serodiagnostic tests for these bacteria are occasionn-
ally performed for FP patients but, to date, results have
always been negative. This means that a positive ser-
ology against Rickettsia spp., C. burnetti, Ehrlichia spp.
or Bartonella spp. should be interpreted with caution. It
is of particular importance because all of these patho-
gens are able to cause unspecific febrile illness associated
with thrombocytopenia, leukopenia, and increased
serum transaminases, which is a common presentation
of dengue, a major public health problem in FP [33].
Conclusions
From our study, we cannot prove that rickettsioses, ehr-
lichioses, bartonelloses and Q fever are absent in FP but
we can consider that, if present, their prevalence is very
low. Further testing of patients with unexplained fever,
will be conducted to confirm the absence of rickettsoses
in this area.
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